Neumann, F.A.O.; Müller, M.; Mattert, G.; Liebig, S.; Herbst, V.; Zapf, D.; Kiderlen, T.R.; Linke, C.; Arp, F.; Deckert, P.M.;
et al. Pneumocystis Jirovecii Pneumonia: The Potential of KEX1, MSG1, and MSG2 as Key Antigens in Cytokine Release Assays. Diagnostics 2025, 15, 793.
https://doi.org/10.3390/diagnostics15070793
AMA Style
Neumann FAO, Müller M, Mattert G, Liebig S, Herbst V, Zapf D, Kiderlen TR, Linke C, Arp F, Deckert PM,
et al. Pneumocystis Jirovecii Pneumonia: The Potential of KEX1, MSG1, and MSG2 as Key Antigens in Cytokine Release Assays. Diagnostics. 2025; 15(7):793.
https://doi.org/10.3390/diagnostics15070793
Chicago/Turabian Style
Neumann, F. A. Ottilie, Markus Müller, Gregor Mattert, Sven Liebig, Victor Herbst, Dorinja Zapf, Til R. Kiderlen, Christian Linke, Franziska Arp, P. Markus Deckert,
and et al. 2025. "Pneumocystis Jirovecii Pneumonia: The Potential of KEX1, MSG1, and MSG2 as Key Antigens in Cytokine Release Assays" Diagnostics 15, no. 7: 793.
https://doi.org/10.3390/diagnostics15070793
APA Style
Neumann, F. A. O., Müller, M., Mattert, G., Liebig, S., Herbst, V., Zapf, D., Kiderlen, T. R., Linke, C., Arp, F., Deckert, P. M., Lüth, S., Schwarzlose-Schwarck, S., Dammermann, W., & Reinwald, M.
(2025). Pneumocystis Jirovecii Pneumonia: The Potential of KEX1, MSG1, and MSG2 as Key Antigens in Cytokine Release Assays. Diagnostics, 15(7), 793.
https://doi.org/10.3390/diagnostics15070793
